✦ LIBER ✦

827 A phase II randomized study comparing docetaxel/clsplatin induction therapy followed by thoracic radiotherapy with or without weekly docetaxel in unresectable stage IIIA–IIIB non-small cell lung cancer

✍ Scribed by C. Manegold; J. Debus; E. Buchholz; G.V. Scagliotti; U. Ricardi; F. Cardenal; K. Mattson; R. Ramlau; A. Szczesna; N. van Zandwijk; A. Price; A. Morel

Book ID: 118620993
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 318 KB
Volume: 1
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(03)90852-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-601 A phase II randomized study of tho

P-601 A phase II randomized study of thoracic radiotherapy with or without weekly docetaxel following docetaxel-cisplatin induction chemotherapy in unresectable stage IIIA-IIIB non-small cell lung cancer

✍ Manegold, Christian; Ramlau, Rodryg; Scagliotti, Giorgio V.; Buchholz, Edith; Sz 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Phase II study of bi-weekly docetaxel an

Phase II study of bi-weekly docetaxel and carboplatin with concurrent thoracic radiation therapy followed by consolidation chemotherapy with docetaxel plus carboplatin for stage III unresectable non-small cell lung cancer

✍ Sakai, H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 93 KB

Induction Chemotherapy With Triweekly Do

Induction Chemotherapy With Triweekly Docetaxel and Cisplatin Followed by Concomitant Chemoradiotherapy With or Without Surgery in Stage III Non–Small-Cell Lung Cancer: A Phase II Study

✍ Adnan Aydiner; Fatma Sen; Esra Kaytan Saglam; Ethem Nezih Oral; Yesim Eralp; Far 📂 Article 📅 2011 🏛 CIG Media Group, LP. 🌐 English ⚖ 500 KB

Long-Term Survival with Concurrent Chemo

Long-Term Survival with Concurrent Chemoradiation Therapy Followed by Consolidation Docetaxel in Stage IIIB Non–Small-Cell Lung Cancer: A Phase II Southwest Oncology Group Study (S9504)

✍ David R. Gandara; Kari Chansky; Kathy S. Albain; Laurie E. Gaspar; Primo N. Lara 📂 Article 📅 2006 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

PD-070 SIGN: A Phase II, open-label, ran

PD-070 SIGN: A Phase II, open-label, randomized study comparinggefitinib (IRESSA) with docetaxel as second-line therapy in patients with advanced (stage IIIb or IV) non-small-cell lung cancer

✍ Cufer, T.; Vrdoljak, E. 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Concurrent Chemoradiotherapy Followed by

Concurrent Chemoradiotherapy Followed by Consolidation Chemotherapy With Bi-Weekly Docetaxel and Carboplatin for Stage III Unresectable, Non-Small-Cell Lung Cancer: Clinical Application of a Protocol Used in a Previous Phase II Study

✍ Jun-Ichi Saitoh; Yoshihiro Saito; Tomoko Kazumoto; Shigehiro Kudo; Daisaku Yoshi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 119 KB